- Home
- MEGL vs POAI Comparison
MEGL vs POAI Comparison
Compare MEGL & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEGL
- POAI
- Stock Information
- Founded
- MEGL 2016
- POAI 2002
- Country
- MEGL Hong Kong
- POAI United States
- Employees
- MEGL N/A
- POAI N/A
- Industry
- MEGL Finance: Consumer Services
- POAI Industrial Specialties
- Sector
- MEGL Finance
- POAI Health Care
- Exchange
- MEGL Nasdaq
- POAI Nasdaq
- Market Cap
- MEGL 6.8M
- POAI 7.8M
- IPO Year
- MEGL 2022
- POAI N/A
- Fundamental
- Price
- MEGL $1.33
- POAI $0.90
- Analyst Decision
- MEGL
- POAI Hold
- Analyst Count
- MEGL 0
- POAI 1
- Target Price
- MEGL N/A
- POAI N/A
- AVG Volume (30 Days)
- MEGL 27.8K
- POAI 159.2K
- Earning Date
- MEGL 10-29-2025
- POAI 08-13-2025
- Dividend Yield
- MEGL N/A
- POAI N/A
- EPS Growth
- MEGL N/A
- POAI N/A
- EPS
- MEGL N/A
- POAI N/A
- Revenue
- MEGL $1,645,862.00
- POAI $1,664,696.00
- Revenue This Year
- MEGL N/A
- POAI $486.27
- Revenue Next Year
- MEGL N/A
- POAI $65.50
- P/E Ratio
- MEGL N/A
- POAI N/A
- Revenue Growth
- MEGL N/A
- POAI 71.65
- 52 Week Low
- MEGL $1.02
- POAI $0.55
- 52 Week High
- MEGL $5.52
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- MEGL 39.06
- POAI 56.68
- Support Level
- MEGL $1.34
- POAI $0.85
- Resistance Level
- MEGL $1.50
- POAI $0.94
- Average True Range (ATR)
- MEGL 0.06
- POAI 0.06
- MACD
- MEGL -0.00
- POAI 0.00
- Stochastic Oscillator
- MEGL 15.00
- POAI 57.74
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.